InflaRx to Present at Annual SVB Leerink Global Health Conference
08 févr. 2022 07h30 HE
|
InflaRx N.V.
JENA, Germany, Feb. 08, 2022 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system,...
InflaRx to Present at Upcoming SVB Leerink Global Healthcare Conference
19 févr. 2020 08h00 HE
|
InflaRx N.V.
JENA, Germany, Feb. 19, 2020 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system,...